197 related articles for article (PubMed ID: 2519931)
21. Monoclonal antibody therapy of cancer.
DiMaggio JJ; Scheinberg DA; Houghton AN
Cancer Chemother Biol Response Modif; 1990; 11():177-203. PubMed ID: 2223394
[No Abstract] [Full Text] [Related]
22. Anti-idiotypes in melanoma.
Ferrone S
Hybridoma; 1993 Oct; 12(5):509-14. PubMed ID: 8300123
[No Abstract] [Full Text] [Related]
23. Active specific immunotherapy: using tumor heterogeneity to successfully fight cancer.
Hanna MG; Howard J; Vermorken J
Hum Vaccin Immunother; 2014; 10(11):3286-96. PubMed ID: 25483649
[No Abstract] [Full Text] [Related]
24. Monoclonal antibodies and tumor vaccines.
Ferrone S
Curr Opin Oncol; 1990 Dec; 2(6):1146-51. PubMed ID: 2099845
[No Abstract] [Full Text] [Related]
25. Cellular vaccine therapies for cancer.
Mastrangelo MJ; Sato T; Lattime EC; Maguire HC; Berd D
Cancer Treat Res; 1998; 94():35-50. PubMed ID: 9587681
[No Abstract] [Full Text] [Related]
26. Using antibodies in tumour immunotherapy.
Schultes BC; Nicodemus CF
Expert Opin Biol Ther; 2004 Aug; 4(8):1265-84. PubMed ID: 15268661
[TBL] [Abstract][Full Text] [Related]
27. Cancer immunotherapy with autologous and allogeneic vaccines: a practical overview.
Shinitzky M; Skornick Y
Prog Clin Biol Res; 1990; 348():95-125. PubMed ID: 2201036
[No Abstract] [Full Text] [Related]
28. Human anti-idiotypic antibodies induced a humoral and cellular immune response against a colorectal carcinoma-associated antigen in patients.
Fagerberg J; Steinitz M; Wigzell H; Askelöf P; Mellstedt H
Proc Natl Acad Sci U S A; 1995 May; 92(11):4773-7. PubMed ID: 7539133
[TBL] [Abstract][Full Text] [Related]
29. Cancer vaccines.
Durrant LG; Spendlove I
QJM; 1996 Sep; 89(9):645-51. PubMed ID: 8917739
[No Abstract] [Full Text] [Related]
30. Possible role of anti-idiotypic antibodies in the induction of tumor immunity.
Kennedy RC; Zhou EM; Lanford RE; Chanh TC; Bona CA
J Clin Invest; 1987 Nov; 80(5):1217-24. PubMed ID: 2824557
[No Abstract] [Full Text] [Related]
31. Future directions in tumor immunotherapy: CTLA4 blockade.
Gulley JL; Dahut WL
Nat Clin Pract Oncol; 2007 Mar; 4(3):136-7. PubMed ID: 17327854
[No Abstract] [Full Text] [Related]
32. Epitope- and antigen-specific cancer vaccines.
Herlyn D; Linnenbach A; Koprowski H; Herlyn M
Int Rev Immunol; 1991; 7(4):245-57. PubMed ID: 1779173
[TBL] [Abstract][Full Text] [Related]
33. Idiotypic antibody immunotherapy of cancer.
Chatterjee MB; Foon KA; Köhler H
Cancer Immunol Immunother; 1994 Feb; 38(2):75-82. PubMed ID: 8306369
[No Abstract] [Full Text] [Related]
34. Active specific immunotherapy with antiidiotypic antibodies in patients with solid tumors.
O'Connell MJ; Chen ZJ; Yang H; Yamada M; Massaro M; Mittelman A; Ferrone S
Semin Surg Oncol; 1989; 5(6):441-7. PubMed ID: 2688034
[TBL] [Abstract][Full Text] [Related]
35. Recent advances in antitumor vaccines.
Hu SL; Hellström I; Hellström KE
Biotechnology; 1992; 20():327-43. PubMed ID: 1318138
[TBL] [Abstract][Full Text] [Related]
36. Report on the Keystone symposium: cellular immunity and the immunotherapy of cancer II.
Lotze MT; Finn OJ
J Immunother Emphasis Tumor Immunol; 1993 Aug; 14(2):79-87. PubMed ID: 8280704
[No Abstract] [Full Text] [Related]
37. Association between induction of anti high molecular weight-melanoma associated antigen (HMW-MAA) immunity with mouse antiidiotypic monoclonal antibody (MoAb) MK2-23 and prolongation of survival in patients with melanoma.
Chen ZJ; Yang H; Liu CC; Mittelman A; Ferrone S
Pigment Cell Res; 1992; Suppl 2():113-22. PubMed ID: 1409413
[No Abstract] [Full Text] [Related]
38. Cancer vaccines.
Pardoll DM
Nat Med; 1998 May; 4(5 Suppl):525-31. PubMed ID: 9585204
[No Abstract] [Full Text] [Related]
39. Modulation of cancer patients' immune responses by anti-idiotypic antibodies.
Herlyn D; Wettendorff M; Koprowski H
Int Rev Immunol; 1989; 4(4):347-57. PubMed ID: 2519932
[TBL] [Abstract][Full Text] [Related]
40. Tumor immunology.
Naftzger C; Houghton AN
Curr Opin Oncol; 1991 Feb; 3(1):93-9. PubMed ID: 2043699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
